BATS BZX Real-Time Price
As of 9:36am ET
| +0.09 / +2.28%|
The 6 analysts offering 12-month price forecasts for Decibel Therapeutics Inc have a median target of 13.00, with a high estimate of 23.00 and a low estimate of 2.00. The median estimate represents a +221.78% increase from the last price of 4.04.
The current consensus among 6 polled investment analysts is to Buy stock in Decibel Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.